Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria Grazia Lazzaroni, Cecília Varjú, Gabriella Nagy et al.|The Journal of Rheumatology|2017Cited by 127
Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled studyAngelo Sangiovanni, Giorgio Minoli, Rino Morales et al.|Hepatology|1998Cited by 91
Lack of EVER2 Protein in Two Epidermodysplasia Verruciformis Patients with Skin Cancer Presenting Previously Unreported Homozygous Genetic Deletions in the EVER2 GeneManuela M. Landini, Marisa Gariglio, Elisa Zavattaro et al.|Journal of Investigative Dermatology|2011Cited by 29